glp 1 psychiatry The Role of GLP-1 Medications in GLP-1 receptor agonists, such as semaglutide, liraglutide, and tirzepatide, have emerged as valuable adjuncts in psychiatry due to their ability to promote weight loss and Glucagon-like Peptide-1 receptor agonists as
Description
Bays H, Pi-Sunyer X, Hemmingsson JU, Claudius B, Jensen CB, Van Gaal L

GPR119 is essential for oleoylethanolamide-induced glucagon-like peptide-1 secretion from the intestinal enteroendocrine L-cell

These searches have been reproduced with almost identical results (66), leading to the definition of acute pancreatitis as an adverse event of special interest in clinical trials of GLP-1RAs

And feel free to comment or ask questions below

Watkins CC, Sawa A, Jaffrey S, Blackshaw S, Barrow RK, Snyder SH, et al

Only one qualitative study has been conducted to date investigating patients taking GLP-1 receptor agonists [31], which focussed on reasons for adherence to the medication
